19,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
10 °P sammeln
  • Broschiertes Buch

Cancer is the second most common cause of mortality and morbidity in kidney transplant recipients. Kidney transplant recipients have at least a twofold higher risk of developing or dying from cancer than the general population.Malignancy is one of the most common causes of death in kidney transplant recipients . In kidney transplant recipients, the incidence of cancer is generally increased 2- to 3-fold compared with the general population . This increased cancer risk is not spread evenly over all types of cancers; while some cancer incidences are not increased (breast, ovarian, brain and…mehr

Produktbeschreibung
Cancer is the second most common cause of mortality and morbidity in kidney transplant recipients. Kidney transplant recipients have at least a twofold higher risk of developing or dying from cancer than the general population.Malignancy is one of the most common causes of death in kidney transplant recipients . In kidney transplant recipients, the incidence of cancer is generally increased 2- to 3-fold compared with the general population . This increased cancer risk is not spread evenly over all types of cancers; while some cancer incidences are not increased (breast, ovarian, brain and cervical cancer), others are increased substantially (lung, colon, liver, lymphoma, melanoma and non-melanoma skin cancer).
Autorenporträt
Bernadett Borda MD.,Ph.D, trabajó en el Departamento de Cirugía de la Universidad de Szeged,Hungría como profesora asistente. Es cirujana, nefróloga e hipertenista.Se doctoró en 2011.